The influence of an antitumor lipid – erucylphosphocholine – on artificial lipid raft system modeled as Langmuir monolayer

References

• Agatha G, Häfer R, Zintil F. 2001. Fatty acid composition of lymphocyte membrane phospholipids in children with acute leukemia. Cancer Lett 173:139–144
   PubMed Web of Science ®Google Scholar
• Ausili A, Torrecillas A, Aranda FJ, Mollinedo F, Gajate C, Corbalan-Garcia S, et al. 2008. Edelfosine is incorporated into rafts and alters their organization. J Phys Chem B 112:11643–11654
   PubMed Web of Science ®Google Scholar
• Beck JG, Mathieu D, Loudet C, Buchoux S, Dufourc EJ. 2007. Plant sterols in “rafts”: a better way to regulate membrane thermal shocks. FASEB J 21:1714–1723
   PubMed Web of Science ®Google Scholar
• Bergkvist M, Carlsson J, Oscarsso S. 2001. A method for studying protein orientation with atomic force microscopy using relative protein volumes. J Phys Chem B 105:2062–2069
   Web of Science ®Google Scholar
• Brzozowska I, Figaszewski ZA. 2002. The equilibrium of phosphatidylcholine-cholesterol in monolayers at the air/water interface. Colloids Surf B 23:51–58
   Web of Science ®Google Scholar
• Cadena-Nava RD, Martin-Mirones JM, Vázques-Martinez EA, Roca JA, Ruiz-Garcia J. 2006. Direct observations of phase changes in Langmuir films of cholesterol. Rev Mex Fis 52:32–40
   Web of Science ®Google Scholar
• Castro BM, Fedorov A, Hornillos V, Delgado J, Acuña AU, Mollinedo F, Prieto M. 2013. Edelfosine and miltefosine effects on lipid raft properties: membrane biophysics in cell death by antitumor lipids. J Phys Chem B 117:7929–7940
   PubMed Web of Science ®Google Scholar
• Davies JT, Rideal EK. 1963. Interfacial phenomena. New York and London: Academic Press
   Google Scholar
• Dick DL, Lawrence DS. 1992. Physicochemical behavior of cytotoxic ether lipids. Biochemistry 31:8252–8527
   PubMed Web of Science ®Google Scholar
• Dynarowicz-Łątka P, Dhanabalan A, Oliviera ON Jr. 1999. A study on two-dimensional phase transitions in Langmuir monolayers of a carboxylic acid with a symmetrical triphenylbenzene ring system. J Phys Chem B 103:5992–6000
   Web of Science ®Google Scholar
• Dynarowicz-Łatka P, Kita K. 1999. Molecular interaction in mixed monolayers at the air/water interface. Adv Colloid Interface Sci 79:1–17
   Web of Science ®Google Scholar
• Eibl H, Hilgard P, Unger C. 1992. Alkylphosphocholines: new drugs in cancer therapy. Basel: Kargel
   Google Scholar
• Eibl H, Kaufmann-Kolle P. 1995. Medical application of synthetic phospholipids as liposomes and drugs. J Liposome Res 5:131–148
   Google Scholar
• Eibl H, Unger C. 1990. Hexadecylphosphocholine: a new and selective antitumor drug. Cancer Treat Rev 17:233–242
   PubMed Web of Science ®Google Scholar
• Fish RG. 1996. Role of gangliosides in tumour progression: a molecular target for cancer therapy? Med Hypotheses 46:140–144
   PubMed Web of Science ®Google Scholar
• Gajate C, Mollinedo F. 2002. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH3 (edelfosine), a proapoptotic agent in tumor cells. Curr Drug Metab 3:491–526
   PubMed Web of Science ®Google Scholar
• Gaus K, Chklovskaia E, Fazekas de St. Groth B, Jessup W, Harder T. 2005. Condensation of the plasma membrane at the site of T lymphocyte activation. J Cell Biol 171:121–131
   PubMed Web of Science ®Google Scholar
• Gomide AB, Thomé CH, dos Santos GA, Ferreira GA, Faça VM, Rego EM, et al. 2013. Disrupting membrane raft domains by alkylphospholipids. Biochim Biophys Acta – Biomembranes 1828:1384–1389
   PubMed Web of Science ®Google Scholar
• Gómez J, Sagués F, Reigada R. 2008. Actively maintained lipid nanodomains in biomembranes. Phys Rev E Stat Nonlin Soft. Matter Phys 77:1–5
   Web of Science ®Google Scholar
• Hanzal-Bayer MF, Hancock JF. 2007. Lipid rafts and membrane traffic. FEBS Lett 581:2098–2104
   PubMed Web of Science ®Google Scholar
• Hardy NJ, Richardson TH, Grunfeld F. 2006. Minimising monolayer collapse on Langmuir troughs. Colloids Surf A 284–285:202–206
   Web of Science ®Google Scholar
• Hąc-Wydro K, Dynarowicz-Łątka P, Wydro P, Bąk K. 2011. Edelfosine disturbs the sphingomyelin-cholesterol model membrane system in a cholesterol-dependent way – the Langmuir monolayer study. Coll Surf B 88:635–640
   PubMed Web of Science ®Google Scholar
• Hąc-Wydro K, Dynarowicz-Łątka P. 2008. The impact of sterol structure on the interactions with sphingomyelin in mixed Langmuir monolayers. J Phys Chem B 112:11324–11332
   PubMed Web of Science ®Google Scholar
• Heczková B, Slotte JP. 2006. Effect of anti-tumor ether lipids on ordered domains in model membranes, FEBS Lett 580:2471–2476
   PubMed Web of Science ®Google Scholar
• Hilgard P, Klenner T, Stekar J, Nössner G, Kutscher B, Engel J. 1997. D-21266, a new heterocyclic alkylphospholipid with antitumour activity. Europ J Cancer 33:442–446
   PubMed Web of Science ®Google Scholar
• Israelachvili JN. 2011. Intermolecular and surface forces, New York: Academic Press
   Google Scholar
• Jablin MS, Flasiński M, Dubey M, Ratnaweera DL, Broniatowski M, Dynarowicz-Łątka P, Majewski J. 2010. Effects of β-cyclodextrin on the structure of sphingomyelin/cholesterol model membranes. Biophys J 99:1475–1481
   PubMed Web of Science ®Google Scholar
• Inbar M, Goldman R, Inbar L, Bursuker I, Goldman B, Akstein E, et al. 1977. Fluidity difference of membrane lipids in human normal and leukemic lymphocytes as controlled by serum components. Cancer Res 37:3037–3041
   PubMed Web of Science ®Google Scholar
• Jendrossek V, Handrick R. 2003. Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisers. Curr Med Chem – Anti-Cancer Agents 3:343–353
   PubMedGoogle Scholar
• Johnson SM, Robinson R. 1979. The composition and fluidity of normal and leukemic or lymphomatous lymphocyte plasma membranes in mouse and man. Biochim Biophys Acta 558:282–295
   PubMed Web of Science ®Google Scholar
• Jurak M, Gołąbek M, Hołysz L, Chibowski E. 2014. Properties of Langmuir and solid supported lipid films with sphingomyelin. Adv Colloid Interface Sci 222:385–397
   PubMed Web of Science ®Google Scholar
• Klock JC, Pieprzyk JK. 1979. Cholesterol, phospholipids, and fatty acids of normal immature neutrophils: comparison with acute myeloblastic leukemia cells and normal neutrophils. J Lipid Res 20:908–911
   PubMed Web of Science ®Google Scholar
• Kondapaka SB, Singh SS, Dasmahapatra GP, Sausville EA, Roy KK. 2003. Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation. Mol Cancer Ther 2:1093–1103
   PubMed Web of Science ®Google Scholar
• Lee K-B, Park S-J, Mirkin CA, Smith JC, Mrksich M. 2002. Protein nanoarrays generated by dip-pen nanolithography. Science 295:1702–1705
   PubMed Web of Science ®Google Scholar
• Li X-M, Smaby JM, Momsen MM, Brockman HL, Brown RE. 2000. Sphingomyelin interfacial behavior: the impact of changing acyl chain composition. Biophys J 78:1921–1931
   PubMed Web of Science ®Google Scholar
• Li Y-C, Park MJ, Ye S-K, Kim C-W, Kim Y-N. 2006. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Path 168:1107–1118
   PubMed Web of Science ®Google Scholar
• Maget-Dana R. 1999. The monolayer technique: a potent tool for studying the interfacial properties of antimicrobial and membrane-lytic peptides and their interactions with lipid membranes. Biochim Biophys Acta 1462:109–140
   PubMed Web of Science ®Google Scholar
• Marsh D. 1996. Lateral pressure in membranes. Biochim Biophys Acta 1286:183–223
   PubMed Web of Science ®Google Scholar
• Mollinedo F, Gajate C. 2006. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. Drug Resist Updat 9:51–73
   PubMed Web of Science ®Google Scholar
• Nieto-Miguel T, Gajate C, Mollinedo F. 2006. Differential targets and subcellular localization of antitumor alkyl-lysophospholipid in leukemic versus solid tumor cells. J Biol Chem 281:14833–14840
   PubMed Web of Science ®Google Scholar
• Ouerghi O, Touhami A, Othmane A, Ben Ouada H, Martelet C, Fretigny C, Jaffrezic-Renault N. 2002. Investigating antibody-antigen binding with atomic force microscopy. Sens Actuators B: Chem 84:167–175
   Web of Science ®Google Scholar
• Pachioni JA, Magalhães JG, Lima EJC, de Moura Bueno L, Barbosa JF, de Sá MM, Rangel-Yagui CO. 2013. Alkylphospholipids – a promising class of chemotherapeutic agents with a broad pharmacological spectrum. J Pharm Sci 16:742–759
   Web of Science ®Google Scholar
• Petelska AD, Figaszewski ZA. 2013. The equilibria of sphingolipid-cholesterol and sphingolipid-sphingolipid in monolayers at the air/water interface. J Membr Sci 246:13–19
   Web of Science ®Google Scholar
• Pike LJ. 2006. Rafts defined: a report on the Keystone symposium on lipid rafts and cell function. J Lipid Res 4:1597–1598
   Web of Science ®Google Scholar
• Poole AR, Howell JI, Lucy JA. 1970. Lysolecithin and cell fusion. Nature 227:810–814
   PubMed Web of Science ®Google Scholar
• Prenner E, Honsek G, Hönig D, Möbius D, Lohner K. 2007. Imaging of the domain organization in sphingomyelin and phosphatidylcholine monolayers. Chem Phys Lipids 145:106–118
   PubMed Web of Science ®Google Scholar
• Ramstedt B, Slotte JP. 2002. Membrane properties of sphingomyelins. FEBS Lett 531:33–37
   PubMed Web of Science ®Google Scholar
• Rübel A, Handrick R, Lindner LH, Steiger M, Eibl H, Budach W, et al. 2006. The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro. Radiat Oncol 1:1–17
   PubMed Web of Science ®Google Scholar
• Simons K, Ikonen E. 1997. Functional rafts in cell membranes. Nature 387:569–572
   PubMed Web of Science ®Google Scholar
• Simons K, Toomre D. 2000. Lipid rafts and signal transduction. Nature 1:31–39
   Web of Science ®Google Scholar
• Smaby JM, Brockman HL, Brown RE. 1994. Cholesterol’s interfacial interactions with sphingomyelins and phosphatidylcholines: hydrocarbon chain structure determines the magnitude of condensation. Biochemistry 33:9135–9142
   PubMed Web of Science ®Google Scholar
• Sok M, Šentjurc M, Schara M. 1999. Membrane fluidity characteristics of human lung cancer. Cancer Lett 139:215–220
   PubMed Web of Science ®Google Scholar
• Thakur G, Pao C, Micic M, Johnson S, Leblanc RM. 2011. Surface chemistry of lipid raft and amyloid Aβ (1–40) Langmuir monolayer. Coll Surf B 87:369–377
   PubMed Web of Science ®Google Scholar
• Van Blitterswijk WJ, Verheij M. 2008. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects. Curr Pharm Des 14:2061–2074
   PubMed Web of Science ®Google Scholar
• Van der Luit AH, Vink SR, Klarenbeek JB, Perrissoud D, Solary E, Verheij M, van Blitterswijk WJ. 2007. A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells. Mol Cancer Ther 6:2337–2345
   PubMed Web of Science ®Google Scholar
• Vila Romeu N, Minones J, Iribarnegaray E, Conde O, Casas M. 1997. Influence of the solvent on the spreading of poly[(D,L-lactic acid)-co-(glycolic acid)] monolayers. Coll Polym Sci 275:580–586
   Web of Science ®Google Scholar
• Wnętrzak A, Łatka K, Dynarowicz-Łatka P. 2013. Interactions of alkylphosphocholines with model membranes – the Langmuir monolayer study. J Membr Biol 246:453–466
   PubMed Web of Science ®Google Scholar
• Wnętrzak A, Łątka K, Dynarowicz-Łątka P, Marzec M. 2012. Langmuir monolayer characteristics of erucylphosphocholine – a novel anti-tumor drug. Acta Phys Pol A 121:468–473
   Web of Science ®Google Scholar
• Wnętrzak A, Łątka K, Dynarowicz-Łątka P. 2014. Interactions between antitumor alkylphosphocholines and membrane sphingolipids in Langmuir monolayers. Acta Phys Pol A 125:886–890
   Web of Science ®Google Scholar